serviceHealth Economics and Outcomes Research (HEOR)

Offering market access support with a deep understanding of the Japanese market

The ultimate goal of pharmaceutical companies, medical device manufacturers and healthcare professionals is to reliably provide optimal healthcare that improves the patient’s life. However, due to rising healthcare expenditures in Japan, the economic value of new treatments is becoming a bigger part of the rules and policies that determine healthcare access and the cost of care for patients. We need to review and communicate both clinically and economically.

We provide a wide range of services to help pharmaceutical companies and medical device manufacturers maximize access to their products in Japan.

Service by Life Cycle of Product

Preclinical Trial

Current treatment/competitive landscape assessment

  • Summarizing of local treatment guidelines
  • Review of local epidemiology (prevalence/incidence)
  • Examination of local pipeline/development plans
  • Identification of unmet medical needs
  • Key stakeholder (related parties/associations) identification

Reimbursement and funding landscape assessment

  • Review of local reimbursement and funding policies
  • Summarizing of past reimbursement decisions

Phase1 Trial

Phase2 Trial

Value evidence strategy planning

  • Identification of key value drivers
  • Optimization of clinical trial design
  • Review of healthcare resource utilization
  • Review of current treatment outcomes/disease burden
  • Modelling of disease progression/survival

Phase3 Trial

Reimbursement/funding strategy development

  • Review of reimbursement landscape
  • Identification of likely reimbursement scenarios
  • Preparation of sales/quantity forecast
  • Development of value proposition story

Value evidence generation

  • Preparation of a budget impact analysis
  • Preparation of a cost-effectiveness/cost-utility analysis
  • Manuscript preparation

Value communication

  • Preparation of reimbursement submission
  • Support with reimbursement oral presentation
  • Development of draft healthcare professional/patient value communications



Post Launch

Value confirmation

  • Update of cost-effectiveness/cost-utility analysis
  • Optimization of post-marketing surveillance
  • Support with patient-reported outcomes
  • Preparation of evidence generation for reimbursement review (value proposition for re-pricing)

We also offer training/workshops on value evidence generation and communication across all stages of product development.

Examples of Research Methods

  • Desktop research
  • Systematic literature reviews/meta-analysis
  • Real-world data (RWD) analysis
  • Disease progression/survival modelling
  • Propensity score matching
  • Focus group interviews
  • Key opinion leader (KOL) interviews
  • Online healthcare professional surveys
  • Online patient surveys
  • Interviews on reimbursement
  • Clinical trial design/implementation
  • Post-marketing surveillance studies
  • Patient-reported outcomes
  • Retrospective medical chart reviews
  • Medical writing

For further information onINTAGE Healthcare Inc.

If you have any questions or comments, please do not hesitate to contact us.

Contact Us



INTAGE Healthcare’s Scope of Service